What to Do with Non-Compliant Hemp Inventory Before November 12

Introduction

With the November 12, 2026 federal compliance deadline now confirmed as fixed — no congressional delay, no administrative reprieve — hemp brands and retailers across the country are facing an increasingly concrete question: what do we do with the inventory that won’t be compliant?

This isn’t a hypothetical. The US Hemp Roundtable has estimated that 95% of hemp products currently on the market will not meet the new 0.4mg total THC per container standard. For brands with any meaningful inventory of these products, how they manage that inventory between now and November 12 will have significant financial and legal consequences.

This article walks through every option available — from the straightforward to the complex — so you can make an informed decision about the right path for your business.

Option 1: Sell Through Before November 12

The simplest strategy is also the most time-constrained: sell your non-compliant inventory before the deadline arrives. Products sold to end consumers before November 12 are legal under the current standard. After November 12, they’re not.

The math on sell-through depends on your current inventory volume, your typical velocity, and how much runway you have. If you have 10 months of inventory at current sales pace and six months until the deadline, sell-through alone won’t work without a significant increase in sales velocity.

Accelerating sell-through may involve discounting, promotional events, or channel expansion into markets where your non-compliant products remain legal and are sold through legitimate retailers. Some brands are running “compliance clearance” promotions that explain the regulatory context to consumers while moving inventory.

What to avoid: Don’t sell non-compliant product into markets where state-level bans are already in effect. Ohio (March 20), and eventually Missouri (November 12), represent markets where even pre-deadline sales of non-compliant products may face state enforcement.

Option 2: Return to Supplier or Distributor

Depending on the terms of your purchase agreements, you may be able to return non-compliant inventory to your supplier or distributor. This option is most available when:

• You have a contractual return clause related to regulatory changes
• Your supplier or distributor bears responsibility for compliance representations
• The non-compliance is attributable to ingredient-level issues rather than your own formulation decisions

Not all suppliers will accept returns, particularly if the non-compliance stems from formulation decisions the brand made rather than ingredient-level issues. But if your COAs showed compliant ingredients and the final product fails total THC testing due to a third-party lab’s error or a processing issue, there may be a valid claim for return or credit.

Review your supplier contracts now. Look for force majeure, regulatory change, or product non-conformity clauses. Engage legal counsel if the value of the inventory justifies it.

Option 3: Reformulate and Repackage

For liquid products — beverages, tinctures, some topicals — reformulation of existing product may be possible before the November 12 deadline. This involves:

• Diluting the cannabinoid concentration to bring the per-container total THC below 0.4mg
• Substituting the non-compliant extract with a compliant broad-spectrum distillate or CBD isolate
• Reducing serving size and repackaging to bring per-container total THC within limits

Reformulation is not always practical — it requires manufacturing capacity, updated COAs, new label artwork, and lead time that may be shorter than the November 12 deadline allows. But for brands with the manufacturing flexibility to execute it, reformulation can preserve product value that would otherwise be lost.

Note that reformulated products need new compliant COAs from ISO 17025-accredited labs before they can be sold as compliant post-November 12 products.

Option 4: Donate to Research or Educational Institutions

In some circumstances, non-compliant hemp inventory can be donated to academic institutions, research organizations, or industrial processing operations for non-consumer-facing applications. This option is narrow but worth evaluating if you have large volumes of inventory that can’t be sold or reformulated.

Donation must be to an institution that can receive hemp materials legally, and the receiving party must use the donated materials in a compliant manner. Hemp fiber, seed, and extract can sometimes be directed toward industrial applications (textiles, bioplastics, research) where cannabinoid content is not a compliance concern.

Document any donation carefully — the last thing you want is a donation transaction that looks like an unlicensed transfer of controlled-substance-adjacent material.

Option 5: Destruction with Documentation

If no other option is viable, controlled destruction of non-compliant inventory is the legally cleanest path. This involves:

• Rendering the product non-recoverable (mixing with non-recyclable waste, incineration, industrial composting where permitted)
• Documenting the destruction with inventory records, dates, methods, and witness signatures where appropriate
• Retaining records in case of future regulatory inquiry

Destruction creates a tax deduction opportunity in most circumstances — consult with your accountant about the appropriate write-off treatment for destroyed inventory. The value you recover via tax deduction is partial compensation for the inventory loss.

Option 6: International Export (Limited Applicability)

In narrow circumstances, hemp-derived products that are non-compliant under U.S. federal law may be exportable to international markets where different standards apply. This is a legally complex path that requires export compliance review, customs documentation, and verification that the destination country’s regulatory framework permits the product.

This option is generally only viable for brands with existing international distribution relationships and the legal infrastructure to execute compliant export transactions. It is not a DIY solution.

Building Your Inventory Action Plan

For most brands, the right approach is a combination of the above options calibrated to your specific inventory mix:

1. Audit your inventory by SKU, volume, and total THC content
2. Assess sell-through velocity and calculate realistic November 12 sell-through projections
3. Identify which products can be reformulated and whether the economics support it
4. Review supplier and distributor contracts for return/credit provisions
5. Quantify the inventory you will not sell through and decide between donation, export, or destruction
6. Consult legal and tax counsel on the financial treatment of destroyed or donated inventory

🌿 LGH Perspective

At Low Gravity Hemp, we’re seeing B2B customers use the inventory transition as a reformulation opportunity — replacing non-compliant extract in their formulations with broad-spectrum distillate or CBD isolate that meets the total THC standard. The reformulation path, combined with aggressive sell-through of existing inventory, is often the best combination for preserving brand value while building a compliant product line for the post-November 12 market. We’re ready to support that transition with compliant ingredients and the COA documentation your new formulations will need.

Final Thoughts

The non-compliant inventory question is one that every hemp brand should be working through right now — not in September, when runway is gone and options have narrowed. Each of the six options above has merit in the right circumstances. Most brands will use a combination. The key is making deliberate decisions with adequate lead time rather than reactive decisions under deadline pressure.

Contact Low Gravity Hemp to discuss compliant hemp ingredients for your reformulation and your path to November 12 readiness.